Correlation Between Pasithea Therapeutics and Forte Biosciences
Can any of the company-specific risk be diversified away by investing in both Pasithea Therapeutics and Forte Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pasithea Therapeutics and Forte Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pasithea Therapeutics Corp and Forte Biosciences, you can compare the effects of market volatilities on Pasithea Therapeutics and Forte Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pasithea Therapeutics with a short position of Forte Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pasithea Therapeutics and Forte Biosciences.
Diversification Opportunities for Pasithea Therapeutics and Forte Biosciences
-0.7 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Pasithea and Forte is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Pasithea Therapeutics Corp and Forte Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Forte Biosciences and Pasithea Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pasithea Therapeutics Corp are associated (or correlated) with Forte Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Forte Biosciences has no effect on the direction of Pasithea Therapeutics i.e., Pasithea Therapeutics and Forte Biosciences go up and down completely randomly.
Pair Corralation between Pasithea Therapeutics and Forte Biosciences
Given the investment horizon of 90 days Pasithea Therapeutics Corp is expected to under-perform the Forte Biosciences. But the stock apears to be less risky and, when comparing its historical volatility, Pasithea Therapeutics Corp is 2.11 times less risky than Forte Biosciences. The stock trades about -0.04 of its potential returns per unit of risk. The Forte Biosciences is currently generating about 0.15 of returns per unit of risk over similar time horizon. If you would invest 700.00 in Forte Biosciences on September 24, 2024 and sell it today you would earn a total of 1,234 from holding Forte Biosciences or generate 176.29% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Pasithea Therapeutics Corp vs. Forte Biosciences
Performance |
Timeline |
Pasithea Therapeutics |
Forte Biosciences |
Pasithea Therapeutics and Forte Biosciences Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Pasithea Therapeutics and Forte Biosciences
The main advantage of trading using opposite Pasithea Therapeutics and Forte Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pasithea Therapeutics position performs unexpectedly, Forte Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Forte Biosciences will offset losses from the drop in Forte Biosciences' long position.Pasithea Therapeutics vs. Nutriband Warrant | Pasithea Therapeutics vs. MediciNova | Pasithea Therapeutics vs. Virax Biolabs Group | Pasithea Therapeutics vs. Revelation Biosciences |
Forte Biosciences vs. Fate Therapeutics | Forte Biosciences vs. Sana Biotechnology | Forte Biosciences vs. Caribou Biosciences | Forte Biosciences vs. Arcus Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins |